SCHEMBL4255907

SCHEMBL4255907

CCC(=O)N1C[C@@H](O)C[C@@H]1C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.65
ACE P12821 1/20 0.41
MME P08473 1/20 0.39
CHRNB2 P17787 3/20 0.39
CHRNA3 P32297 3/20 0.39
CHRNA4 P43681 3/20 0.39
CHRNB3 Q05901 1/20 0.39
CHRNA6 Q15825 1/20 0.39
RIPK1 Q13546 1/20 0.37
VHL P40337 1/20 0.36
CHRNB4 P30926 2/20 0.36
CHRNA7 P36544 2/20 0.36
PIK3CD O00329 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MEN1 O00255 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4251815 1.00 ATM (0.65) ATMACEMMECHRNB2CHRNA3
SCHEMBL2544923 1.00 ATM (0.65) ATMACEMMECHRNB2CHRNA3
SCHEMBL4251813 1.00 ATM (0.65) ATMACEMMECHRNB2CHRNA3
SCHEMBL4255909 1.00 ATM (0.65) ATMACEMMECHRNB2CHRNA3
SCHEMBL4256292 1.00 ATM (0.65) ATMACEMMECHRNB2CHRNA3
SCHEMBL4250843 0.86 ATM (0.61) ATMACEMMECHRNB2CHRNA3
SCHEMBL4258847 0.86 ATM (0.61) ATMACEMMECHRNB2CHRNA3
SCHEMBL4252592 0.86 ATM (0.61) ATMACEMMECHRNB2CHRNA3
SCHEMBL4254729 0.86 ATM (0.61) ATMACEMMECHRNB2CHRNA3
SCHEMBL2032330 0.86 ATM (0.61) ATMACEMMECHRNB2CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111632095-A Antibacterial vagina tightening and contracting composition and application thereof 上海赫依美容美体有限公司 2020-09-08 CN disclosed
US-8338404-B2 Composition and method for reducing allergen KYOWA HAKKO BIO CO., LTD. (JP) 2012-12-25 US disclosed
US-20090069403-A1 COMPOSITION AND METHOD FOR REDUCING ALLERGEN KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-03-12 US disclosed
US-20080188546-A1 Preventive or therapeutic agents for decubitus TAKEDA TOSHIAKI 2008-08-07 US disclosed
US-20080102042-A1 Dentifrices containing N-acyl derivative of hydroxyproline; periodontal disease KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-05-01 US disclosed
US-20070293559-A1 Orally Administered Agent For Preventing Or Improving Dry Station Of Skin KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-12-20 US disclosed
CN-101027050-A Oral preparation for preventing or improving dry skin KYOWA HAKKO KOGYO KK (JP) 2007-08-29 CN disclosed
EP-1795191-A1 ORAL PHARMACEUTICAL FOR DRY SKIN PREVENTION OR REMEDY KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-06-13 EP disclosed
US-20060034781-A1 PERORAL PREPARATION FOR PREVENTION OR TREATMENT OF ATOPIC DERMATATIS KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-02-16 US disclosed
US-20060035957-A1 Preventive or remedy for bedsore KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-02-16 US disclosed
EP-1559425-A1 PERORAL PREPARATION FOR PREVENTION OF OR TREATMENT FOR ATOPIC DERMATITIS KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-08-03 EP disclosed
EP-1547594-A1 PREVENTIVE OR REMEDY FOR BEDSORE KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-06-29 EP disclosed
US-20030185864-A1 Preventives or remedies for atopic dermatitis KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-10-02 US disclosed
EP-1304323-A1 PREVENTIVES OR REMEDIES FOR ATOPIC DERMATITIS KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069403-A1 COMPOSITION AND METHOD FOR REDUCING ALLERGEN TSLP, CARM1, CMA1 ATM 2585/4885ACE 103/4885MME 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.